# Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty

> **NCT02349542** · PHASE4 · COMPLETED · sponsor: **OrthoCarolina Research Institute, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Arthroplasty, Replacement, Knee
- Pain

## Interventions

- **DRUG:** Liposomal bupivacaine

## Key facts

- **NCT ID:** NCT02349542
- **Lead sponsor:** OrthoCarolina Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-11-01
- **Final completion:** 2016-11-21
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349542, "Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02349542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*